Clearing Brain Fog and Fatigue in Long COVID and CFS - Can AlphaGPC & Creatine Help?

Clearing Brain Fog and Fatigue in Long COVID and CFS - Can AlphaGPC & Creatine Help?

Creatine & AlphaGPC: Can they help clear brain fog and fatigue in Long COVID and Chronic Fatigue Syndrome?

Long COVID (also called post-COVID condition or PCC) and chronic fatigue syndrome share overlapping challenges: profound fatigue, post-exertional malaise (PEM), brain fog, difficulty concentrating, muscle weakness, headaches, and reduced quality of life.

Emerging research points to impaired cellular energy production (mitochondrial dysfunction and bioenergetic deficits) and disruptions in brain signaling as key contributors.

Two supplements - creatine and Alpha-GPC- are gaining attention as targeted tools to support energy metabolism and cognitive function in these conditions. Creatine primarily fuels rapid ATP regeneration in muscles and the brain, while Alpha-GPC supports acetylcholine production for focus, memory, and mental clarity. Together, they may address both the physical and neurological aspects of fatigue and brain fog.

In this blog we're exploring the science, mechanisms, evidence, and practical use of these compounds, drawing from clinical studies in post-viral fatigue syndromes.

 

Creatine: Replenishing Cellular Energy Stores

Creatine is a naturally occurring compound synthesized in the body and obtained from meat/fish. In cells, it is phosphorylated to phosphocreatine, which acts as a rapid reserve to regenerate ATP (the cell’s energy currency) during high-demand activities via the creatine kinase reaction.In Long COVID and ME/CFS, research suggests reduced creatine levels in skeletal muscle and brain tissue, contributing to fatigue and impaired recovery. Supplementation can increase phosphocreatine stores, supporting better energy buffering, reduced oxidative stress, and improved bioenergetics.


Key Evidence in Long COVID and Related Conditions:

  • A 2023 study (Slankamenac et al.) gave participants with post-COVID-19 fatigue syndrome 4 g/day of creatine monohydrate for 6 months. It significantly increased creatine levels in muscle (vastus medialis) and brain white matter, reduced general fatigue after 3 months, and improved multiple symptoms at 6 months—including breathing difficulties, body aches, headaches, loss of taste, and concentration problems—compared to baseline and placebo. No major side effects were reported.
    pmc.ncbi.nlm.nih.gov
  • A randomized trial using 6 g/day found improvements in fatigue scores (PFS-R) and handgrip strength in people with post-COVID condition, with good tolerability.
    frontiersin.org
  • Other trials (e.g., 4–8 g/day regimens) have shown benefits for fatigue, cognitive symptoms, and exercise tolerance in post-viral fatigue, with increases in brain creatine on imaging.

Benefits often build over weeks to months, aligning with the time needed to saturate tissue stores.

 

Alpha-GPC: Enhancing Brain Signaling and Cognition

Alpha-GPC (alpha-glycerylphosphorylcholine or choline alfoscerate) is a highly bioavailable choline compound that crosses the blood-brain barrier efficiently. It serves as a precursor to acetylcholine, the primary neurotransmitter for memory, attention, learning, and muscle control. It also supports phosphatidylcholine synthesis for healthy cell membranes and may offer neuroprotective effects.

Brain fog in Long COVID and ME/CFS often involves cognitive slowing, poor focus, and mental fatigue - areas where cholinergic support can help. Alpha-GPC has a strong track record in cognitive enhancement, particularly in aging or impaired states.Evidence and Relevance:

  • Clinical studies show Alpha-GPC improves cognition, memory, and attention in mild cognitive impairment, dementia, and vascular brain conditions.
  • In post-COVID contexts, choline alfoscerate (Alpha-GPC) has been studied for fatigue and cognitive impairment, with positive signals for symptom relief in observational or combined protocols.
    nnp.ima-press.net
  • General benefits include better mental clarity and focus, which can indirectly support energy by reducing the cognitive load of daily tasks. Some research also links it to mitochondrial support and reduced oxidative stress.

Typical studied doses for cognitive support range from 300–600 mg/day (up to 1,200 mg/day in some clinical settings for impairment).

 

The Synergistic Potential of Creatine + Alpha-GPC

Creatine tackles the “power plant” side (cellular ATP regeneration in brain and muscle), while Alpha-GPC supports the “control systems” (neurotransmitter balance and membrane health). This combination may offer complementary benefits for the dual physical and mental fatigue common in Long COVID and ME/CFS.By improving energy availability and cognitive processing, the pair could help with:

  • Reduced brain fog and better concentration
  • Improved physical stamina and recovery
  • Overall resilience against PEM triggers

While direct combination trials are limited, the individual mechanisms and overlapping benefits in energy/cognition make them a logical stack. Some broader research on choline and energy metabolism in post-viral states supports exploring such targeted approaches.

 

Practical Supplementation Guide

Creatine Monohydrate (most researched, cost-effective form):

  • Dose: 3–5 g per day (studies in Long COVID often used 4–6 g). A loading phase (20 g/day split for 5–7 days) is optional but not required.
  • Timing: Any time of day; consistency matters more than timing. Take with a meal or carbs for better uptake.
  • Form: Micronized powder mixes well; capsules for convenience.

Alpha-GPC:

  • Dose: 300–600 mg per day (start at 300 mg). Split doses if using higher amounts (e.g., morning and early afternoon).
  • Timing: With food or before mentally demanding tasks.
  • Form: Powder or capsules; look for high-purity products.

Stacking Tips:

  • Take both daily for synergistic effects.
  • Cycle or monitor long-term (many use continuously with periodic breaks).
  • Stay hydrated (especially with creatine).
  • Track symptoms (fatigue scales, cognitive journals, PEM frequency) to assess response - benefits often appear after 4–12+ weeks.

Safety and Side Effects: Both are generally well-tolerated with strong safety profiles in studies.

  • Creatine: Mild water retention/weight gain (1–3 lbs), possible GI upset. Rare concerns with pre-existing kidney issues—consult a doctor and consider baseline kidney function tests for long-term use.
    unmc.edu
  • AlphaGPC: Usually minimal; high doses may cause headache, dizziness, or insomnia in sensitive individuals (cholinergic effects). Start low and titrate.General: Not recommended as a standalone treatment.
  • Combine with exercise, nutrition, sleep optimization, and medical care. Consult a healthcare provider before starting, especially if you have medical conditions, take medications, or are pregnant/breastfeeding. Third-party tested supplements are ideal for purity.

 

Bottom Line

Emerging clinical evidence - particularly robust data for creatine in post-COVID fatigue and supportive data for Alpha-GPC in cognitive function - suggests these supplements can be valuable tools for supporting energy production and mental clarity in Long COVID, ME/CFS, and related energy-impairing conditions.

Creatine helps restore bioenergetic capacity, while Alpha-GPC bolsters brain chemistry for focus and resilience.Results vary by individual; they work best as part of a comprehensive, personalized plan under professional guidance.

 

 

*Disclaimer: This is for educational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting any supplement regimen. Individual responses differ, and supplements are not cures

 

Resources:



 

Back to blog